Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

"It has been an exciting start," Solventum CEO Bryan Hanson said of the 3M Health Care spinoff's first two quarters.

Baxter expects to lose out on at least $200 million worth of sales due to Hurricane Helene's flooding at its North Cove ...